MIMS and Ashfield Healthcare Communications join forces in strategic alliance.

21 Jan 12:00 AM

MIMS, Asia’s largest multi-channel provider of drug information, medical communications, events management and marketing services, and Ashfield Healthcare Communications, are pleased to announce the creation of a new global alliance.

Ashfield Healthcare Communications, part of UDG Healthcare plc, provides global solutions for clients, adding value by connecting insight, intelligence, and expertise to flawlessly execute powerful, multichannel communication solutions. Ashfield Healthcare Communications has a global network of 1,300 employees collaborating with more than 100 pharma, biotech, device and nutraceutical companies.

For over 50 years, MIMS has been a trusted medical knowledge source dedicated to empowering healthcare professionals. MIMS’ diverse expertise from data-driven marketing and events management to scientific strategy and digital medication safety solutions. Today MIMS is present in 16 markets across Asia Pacific with approximately two million healthcare professional subscribing to its drug and resource portal, digital and print publications, the only one of its kind in the region.

In light of an increasing trend amongst pharmaceutical companies to conduct launches, scientific meetings and marketing programs across multiple territories, Ashfield Healthcare Communications and MIMS recognised the need for, and value of, establishing a non-holding company approach to their current and future client relationships, complementing each other’s geographic reach and ultimately providing streamlined agility in the delivery of their healthcare communications capabilities.

The synergy between MIMS and Ashfield is the ability to take the compliance-based local knowledge within these countries and execute global programs at the local level. Both are capable of producing heavy-duty, highly scientific healthcare communications, which will now reach across Asia, US, and Europe.

Ashfield Healthcare Communications President Doug Burcin said: “I am delighted with the creation of this strategic partnership. Ashfield Healthcare Communications operate in the US, Japan, and Europe and now with MIMS we are able to extend our services throughout Asia Pacific. Together, our alliance expands global and local delivery for Ashfield clients to an additional 16 APAC countries and provides unprecedented expertise and cross-collaboration of healthcare communications by both parties.

Victor Wright, Chief Client Officer of pharma marketing for MIMS, said: “The partnership with Ashfield will form the largest and most comprehensive high-science medical communications network globally. The collaboration will provide us both with additional expertise and territories, opening up fantastic opportunities to deliver the best for our international pharmaceutical, biotech, and medical devices clients.”

 

 

For more information on Ashfield Healthcare Communications, visit www.ashfieldhealthcare.com and for MIMS, visit http://corporate.mims.com or www.mimsmc.com for medical communications services.

 

For further information and interview opportunities with Ashfield, please contact Lara Lovenbury at ramarketing:

lara@ramarketingpr.com

07972471903

0191 222 1242

www.ramarketingpr.com